NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer

NCT00994097 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: NGR-hTNF
DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: Pemetrexed

Sponsor

AGC Biologics S.p.A.